<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37410912</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells.</ArticleTitle><Pagination><StartPage>3624</StartPage><EndPage>3633</EndPage><MedlinePgn>3624-3633</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awad228</ELocationID><Abstract><AbstractText>The centrosome, as the main microtubule organizing centre, plays key roles in cell polarity, genome stability and ciliogenesis. The recent identification of ribosomes, RNA-binding proteins and transcripts at the centrosome suggests local protein synthesis. In this context, we hypothesized that TDP-43, a highly conserved RNA binding protein involved in the pathophysiology of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, could be enriched at this organelle. Using dedicated high magnification sub-diffraction microscopy on human cells, we discovered a novel localization of TDP-43 at the centrosome during all phases of the cell cycle. These results were confirmed on purified centrosomes by western blot and immunofluorescence microscopy. In addition, the co-localization of TDP-43 and pericentrin suggested a pericentriolar enrichment of the protein, leading us to hypothesize that TDP-43 might interact with local mRNAs and proteins. Supporting this hypothesis, we found four conserved centrosomal mRNAs and 16 centrosomal proteins identified as direct TDP-43 interactors. More strikingly, all the 16 proteins are implicated in the pathophysiology of TDP-43 proteinopathies, suggesting that TDP-43 dysfunction in this organelle contributes to neurodegeneration. This first description of TDP-43 centrosomal enrichment paves the way for a more comprehensive understanding of TDP-43 physiology and pathology.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bodin</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology and neuropathology, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greibill</LastName><ForeName>Logan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris Sud, Universit&#xe9; Paris-Saclay, 91190 Gif sur Yvette, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouju</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurobiology and neuropathology, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letournel</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurobiology and neuropathology, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzi</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, University of Laval, Qu&#xe9;bec City, Qc G1V 0A6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec, Qc G1E 1T2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julien</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, University of Laval, Qu&#xe9;bec City, Qc G1V 0A6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec, Qc G1E 1T2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renaud</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qc H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de recherche sur le syst&#xe8;me nerveux central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qc H3C 3J7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bohl</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millecamps</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verny</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Amyotrophic Lateral Sclerosis Center, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cassereau</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Amyotrophic Lateral Sclerosis Center, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenaers</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Amyotrophic Lateral Sclerosis Center, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevrollier</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassin</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris Sud, Universit&#xe9; Paris-Saclay, 91190 Gif sur Yvette, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Codron</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1745-8299</Identifier><AffiliationInfo><Affiliation>Univ Angers, Equipe MitoLab, Unit&#xe9; MitoVasc, Inserm U1083, CNRS 6015, SFR ICAT, 49100 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology and neuropathology, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Amyotrophic Lateral Sclerosis Center, University-Hospital of Angers, 49933 Angers, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2023 Aug 04;:</RefSource><PMID Version="1">37540028</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018385" MajorTopicYN="N">Centrosome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">centrosome</Keyword><Keyword MajorTopicYN="N">pericentriolar matrix</Keyword></KeywordList><CoiStatement>The authors report no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37410912</ArticleId><ArticleId IdType="pmc">PMC10473568</ArticleId><ArticleId IdType="doi">10.1093/brain/awad228</ArticleId><ArticleId IdType="pii">7220662</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T, Hasegawa M, Akiyama H, et al. . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, et al. . Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report. Brain. 2019;142:1503&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, et al. . TARDBP Mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al. . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zein-Sabatto H, Lerit DA. The identification and functional analysis of mRNA localizing to centrosomes. Front Cell Dev Biol. 2021;9:782802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595238</ArticleId><ArticleId IdType="pubmed">34805187</ArticleId></ArticleIdList></Reference><Reference><Citation>Safieddine A, Coleno E, Salloum S, et al. . A choreography of centrosomal mRNAs reveals a conserved localization mechanism involving active polysome transport. Nat Commun. 2021;12:1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921559</ArticleId><ArticleId IdType="pubmed">33649340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouaib R, Safieddine A, Pichon X, et al. . A dual protein-mRNA localization screen reveals compartmentalized translation and widespread co-translational RNA targeting. Dev Cell. 2020;54:773&#x2013;791.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32783880</ArticleId></ArticleIdList></Reference><Reference><Citation>Codron P, Cassereau J, Vourc'h P, et al. . Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(5&#x2013;6):446&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">29382228</ArticleId></ArticleIdList></Reference><Reference><Citation>Journe-Mallet I, Gouju J, Etcharry-Bouyx F, et al. . Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases. Brain Pathol. 2023;33:e13138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154372</ArticleId><ArticleId IdType="pubmed">36536531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassin AM, Celati C, Moudjou M, Bornens M. Characterization of the human homologue of the yeast spc98p and its association with gamma-tubulin. J Cell Biol. 1998;141:689&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132749</ArticleId><ArticleId IdType="pubmed">9566969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff A, de N&#xe9;chaud B, Chillet D, et al. . Distribution of glutamylated alpha and beta-tubulin in mouse tissues using a specific monoclonal antibody, GT335. Eur J Cell Biol. 1992;59:425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">1493808</ArticleId></ArticleIdList></Reference><Reference><Citation>Codron P, Letournel F, Marty S, et al. . STochastic optical reconstruction microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain. Neuropathol Appl Neurobiol. 2021;47:127&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7891317</ArticleId><ArticleId IdType="pubmed">32688444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogendeau D, Guichard P, Tassin AM. Purification of centrosomes from mammalian cell lines. Methods Cell Biol. 2015;129:171&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">26175439</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailly E, Dor&#xe9;e M, Nurse P, Bornens M. P34cdc2 is located in both nucleus and cytoplasm; part is centrosomally associated at G2/M and enters vesicles at anaphase. EMBO J. 1989;8:3985&#x2013;3995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC401573</ArticleId><ArticleId IdType="pubmed">2686978</ArticleId></ArticleIdList></Reference><Reference><Citation>Stearns T, Evans L, Kirschner M. Gamma-tubulin is a highly conserved component of the centrosome. Cell. 1991;65:825&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pubmed">1840506</ArticleId></ArticleIdList></Reference><Reference><Citation>Doxsey SJ, Stein P, Evans L, Calarco PD, Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell. 1994;76:639&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">8124707</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, Kopito RR. Aggresomes: A cellular response to misfolded proteins. J Cell Biol. 1998;143:1883&#x2013;1898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosser SL, Tkach J, Gheiratmand L, et al. . Aggresome assembly at the centrosome is driven by CP110-CEP97-CEP290 and centriolar satellites. Nat Cell Biol. 2022;24:483&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9033585</ArticleId><ArticleId IdType="pubmed">35411088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennella V, Keszthelyi B, McDonald KL, et al. . Subdiffraction-resolution fluorescence microscopy reveals a domain of the centrosome critical for pericentriolar material organization. Nat Cell Biol. 2012;14:1159&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767400</ArticleId><ArticleId IdType="pubmed">23086239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang B, Armaos A, Tartaglia GG. RNAct: Protein-RNA interaction predictions for model organisms with supporting experimental data. Nucleic Acids Res. 2019;47(D1):D601&#x2013;D606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324028</ArticleId><ArticleId IdType="pubmed">30445601</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand EL, Pratt GA, Shishkin AA, et al. . Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods. 2016;13:508&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4887338</ArticleId><ArticleId IdType="pubmed">27018577</ArticleId></ArticleIdList></Reference><Reference><Citation>Oughtred R, Rust J, Chang C, et al. . The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737760</ArticleId><ArticleId IdType="pubmed">33070389</ArticleId></ArticleIdList></Reference><Reference><Citation>UniProt Consortium . Uniprot: The universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480&#x2013;D489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778908</ArticleId><ArticleId IdType="pubmed">33237286</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, Fagerberg L, Hallstr&#xf6;m BM, et al. . Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.</Citation><ArticleIdList><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Gentil BJ, Gros-Louis F, Rouleau G, Julien JP. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta. 2005;1745:84&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085057</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Hentati A, Deng HX, et al. . The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Hand CK, Osuga H, et al. . A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnazzo MM, Uhlemann EME, Villarreal AR, Shirayama M, Dominguez EG, Skop AR. The RNA-binding protein ATX-2 regulates cytokinesis through PAR-5 and ZEN-4. Mol Biol Cell. 2016;27:3052&#x2013;3064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063614</ArticleId><ArticleId IdType="pubmed">27559134</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubenvoll MD, Medley JC, Irwin M, Song MH. ATX-2, the C. elegans ortholog of human ataxin-2, regulates centrosome size and microtubule dynamics. PLoS Genet. 2016;12:e1006370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5045193</ArticleId><ArticleId IdType="pubmed">27689799</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, et al. . Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart MP, Gitler AD. ALS-Associated Ataxin 2 PolyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci. 2012;32:9133&#x2013;9142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418890</ArticleId><ArticleId IdType="pubmed">22764223</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu LC, White RL. BRCA1 Is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A. 1998;95:12983&#x2013;12988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23679</ArticleId><ArticleId IdType="pubmed">9789027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, Mordes DA, Cameron LA, et al. . Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci U S A. 2016;113:E7701&#x2013;E7709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Noristani HN, Sabourin JC, Gerber YN, et al. . Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS. Mol Neurodegeneration. 2015;10:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521418</ArticleId><ArticleId IdType="pubmed">26227626</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angiolella V, Donato V, Vijayakumar S, et al. . SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature. 2010;466:138&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946399</ArticleId><ArticleId IdType="pubmed">20596027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner SL, Yang S, Farrawell NE, et al. . TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex. Neurobiol Dis. 2022;167:105673.</Citation><ArticleIdList><ArticleId IdType="pubmed">35231559</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Topp S, Yang S, et al. . CCNF Mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. 2016;7:11253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Taubenberger A, Ishikawa-Ankerhold HC, Kastner PM, Burghardt E, Gerisch G. The STE group kinase SepA controls cleavage furrow formation in Dictyostelium. Cell Motil Cytoskeleton. 2009;66:929&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">19479821</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC. CDC7 Inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration: CDC7 and TDP-43 pathology. Ann Neurol. 2013;74:39&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775949</ArticleId><ArticleId IdType="pubmed">23424178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaca G, Martinez-Gonzalez L, Fernandez A, et al. . Therapeutic potential of novel cell division cycle kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). J Neurochem. 2021;156:379&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">32628315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott C, Nachmias D, Adar S, et al. . VPS4 Is a dynamic component of the centrosome that regulates centrosome localization of &#x3b3;-tubulin, centriolar satellite stability and ciliogenesis. Sci Rep. 2018;8:3353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820263</ArticleId><ArticleId IdType="pubmed">29463826</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X, Sun X, Yue W, et al. . CHMP2B Regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1. J Cell Biol. 2022;221:e202103033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8570292</ArticleId><ArticleId IdType="pubmed">34726688</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G, Parkinson NJ, Brown JM, et al. . Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37:806&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N, Ince PG, Smith MO, et al. . ALS Phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 2006;67:1074&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer YE, Westlake CJ, Gao B, et al. . Casein kinase 1&#x3b4; functions at the centrosome and Golgi to promote ciliogenesis. Mol Biol Cell. 2014;25:1629&#x2013;1640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019494</ArticleId><ArticleId IdType="pubmed">24648492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Nonaka T, Suzuki T, et al. . Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun. 2009;382:405&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Suzuki G, Tanaka Y, et al. . Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1&#x3b4; triggers mislocalization and accumulation of TDP-43. J Biol Chem. 2016;291:5473&#x2013;5483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C, Salado IG, de la Encarnaci&#xf3;n A, et al. . Targeting TDP-43 phosphorylation by casein kinase-1&#x3b4; inhibitors: A novel strategy for the treatment of frontotemporal dementia. Mol Neurodegeneration. 2016;11:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4852436</ArticleId><ArticleId IdType="pubmed">27138926</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguether T, Ermolaeva MA, Zhao Y, et al. . The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells. Nat Commun. 2014;5:4585.</Citation><ArticleIdList><ArticleId IdType="pubmed">25134987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C, Hallupp M, Shahheydari H, et al. . CYLD Is a causative gene for frontotemporal dementia&#x2014;Amyotrophic lateral sclerosis. Brain. 2020;143:783&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodani A, Salom&#xe9; Sirerol-Piquer M, Seol A, Manuel Garcia-Verdugo J, Reiter JF. Kif3a interacts with dynactin subunit p150 glued to organize centriole subdistal appendages. EMBO J. 2013;32:597&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3579144</ArticleId><ArticleId IdType="pubmed">23386061</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhapparova ON, Fokin AI, Vorobyeva NE, Bryantseva SA, Nadezhdina ES. Ste20-like protein kinase SLK (LOSK) regulates microtubule organization by targeting dynactin to the centrosome. Mol Biol Cell. 2013;24:3205&#x2013;3214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3806656</ArticleId><ArticleId IdType="pubmed">23985322</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshimaru M, Kinoshita-Kawada M, Kubota K, et al. . DCTN1 Binds to TDP-43 and regulates TDP-43 aggregation. Int J Mol Sci. 2021;22:3985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070438</ArticleId><ArticleId IdType="pubmed">33924373</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno T, Ross OA, Teive HAG, S&#x142;awek J, Dickson DW, Wszolek ZK. DCTN1-related Neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord. 2017;41:14&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546300</ArticleId><ArticleId IdType="pubmed">28625595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WJ, Wang WT, Tsai TY, Li HK, Lee YHW. DDX3 Localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression. Sci Rep. 2017;7:9411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573351</ArticleId><ArticleId IdType="pubmed">28842590</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Zhang Z, et al. . CRISPR-Cas9 Screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron. 2019;104:885&#x2013;898.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippova N, Yang X, King P, Nabors LB. Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome function. J Biol Chem. 2012;287:32277&#x2013;32287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442558</ArticleId><ArticleId IdType="pubmed">22829587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Zheng L, Si Y, et al. . Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS. J Biol Chem. 2014;289:31792&#x2013;31804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231657</ArticleId><ArticleId IdType="pubmed">25239623</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsye P, Zheng L, Si Y, et al. . Hur promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases. Glia. 2017;65:945&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7944581</ArticleId><ArticleId IdType="pubmed">28300326</ArticleId></ArticleIdList></Reference><Reference><Citation>Leemann-Zakaryan RP, Pahlich S, Sedda MJ, Quero L, Grossenbacher D, Gehring H. Dynamic subcellular localization of the Ewing sarcoma proto-oncoprotein and its association with and stabilization of microtubules. J Mol Biol. 2009;386:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19133275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B, O&#x2019;Connell JD, Yamazaki T, Gangopadhyay J, Gygi SP, Reed R. Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins. Sci Rep. 2018;8:8755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993797</ArticleId><ArticleId IdType="pubmed">29884807</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Erion R, et al. . Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:2899&#x2013;2911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino Y, Ishioka C. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Sci Rep. 2015;5:13249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4543981</ArticleId><ArticleId IdType="pubmed">26292722</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, James JL, Parker SJ, et al. . Kinase inhibitor screening identifies cyclin-dependent kinases and glycogen synthase kinase 3 as potential modulators of TDP-43 cytosolic accumulation during cell stress. PLoS One. 2013;8:e67433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3694067</ArticleId><ArticleId IdType="pubmed">23840699</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HJ, Cha SJ, Lee JW, Kim HJ, Kim K. Recent advances on the role of GSK3&#x3b2; in the pathogenesis of amyotrophic lateral sclerosis. Brain Sci. 2020;10:675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600609</ArticleId><ArticleId IdType="pubmed">32993098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran J, Yang Y, Li D, Liu M, Zhou J. Deacetylation of &#x3b1;-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci Rep. 2015;5:12917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526867</ArticleId><ArticleId IdType="pubmed">26246421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron ML, Lonskaya I, Sharpe K, et al. . Parkin ubiquitinates tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem. 2013;288:4103&#x2013;4115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazal R, Boeynaems S, Swijsen A, et al. . HDAC6 Inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 2021;40:e106177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013789</ArticleId><ArticleId IdType="pubmed">33694180</ArticleId></ArticleIdList></Reference><Reference><Citation>White MC, Quarmby LM. The NIMA-family kinase, nek1 affects the stability of centrosomes and ciliogenesis. BMC Cell Biol. 2008;9:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442590</ArticleId><ArticleId IdType="pubmed">18533026</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, M&#xfc;ller K, Wieland T, et al. . NEK1 Mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139(Pt 5):e28.</Citation><ArticleIdList><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejedl&#xe1; M, Klebanovych A, Sulimenko V, et al. . The actin regulator profilin 1 is functionally associated with the mammalian centrosome. Life Sci Alliance. 2021;4:e202000655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668531</ArticleId><ArticleId IdType="pubmed">33184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hasegawa M. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum Mol Genet. 2016;25:1420&#x2013;1433.</Citation><ArticleIdList><ArticleId IdType="pubmed">26908597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH, Fallini C, Ticozzi N, et al. . Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannon JH, O&#x2019;Donovan DS, Kennelly SME, Mc Gee MM. The peptidyl prolyl isomerase cyclophilin A localizes at the centrosome and the midbody and is required for cytokinesis. Cell Cycle. 2012;11:1340&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pubmed">22421161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauranzano E, Pozzi S, Pasetto L, et al. . Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes. Brain. 2015;138:974&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">25678563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasetto L, Grassano M, Pozzi S, et al. . Defective cyclophilin A induces TDP-43 proteinopathy: Implications for amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2021;144:3710&#x2013;3726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719849</ArticleId><ArticleId IdType="pubmed">34972208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai S, Nguyen J, Johnson J, Haura E, Coppola D, Chellappan S. Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis. Nat Commun. 2015;6:10072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4682058</ArticleId><ArticleId IdType="pubmed">26656453</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, et al. . Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, et al. . Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;aj&#xe1;nek L, Nigg EA. Cep164 triggers ciliogenesis by recruiting tau tubulin kinase 2 to the mother centriole. Proc Natl Acad Sci U S A. 2014;111:E2841&#x2013;E2850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4104846</ArticleId><ArticleId IdType="pubmed">24982133</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, McMillan PJ, Strovas TJ, et al. . The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43. PLoS Genet. 2014;10:e1004803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256087</ArticleId><ArticleId IdType="pubmed">25473830</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LM, McMillan PJ, Liachko NF, et al. . Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener. 2018;13:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802059</ArticleId><ArticleId IdType="pubmed">29409526</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestra FR, Strnad P, Fl&#xfc;ckiger I, G&#xf6;nczy P. Discovering regulators of centriole biogenesis through siRNA-based functional genomics in human cells. Dev Cell. 2013;25:555&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">23769972</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeo F, Schlauer J, Zischka H, Mecke D, Fr&#xf6;hlich KU. Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p. Mol Biol Cell. 1998;9:131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25228</ArticleId><ArticleId IdType="pubmed">9436996</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts GDJ, Wymer J, Kovach MJ, et al. . Inclusion body myopathy associated with paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer BC, Schuck T, Wheeler JM, et al. . Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, Good SK, Atkin S, et al. . TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285:6826&#x2013;6834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu LS, Cheng WC, Hou SC, Yan YT, Jiang ST, Shen CK. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis. 2010;48:56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">20014337</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Katsuno M, Niwa J, et al. . Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain. 2013;136(Pt 5):1371&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>